Habika HCT Tablet 5/20/12.5 mg

Adult dose

This medication should be taken once daily, one tablet with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The maximum dosage is 10/40/25 mg of Amlodipine/Olmesartan Medoxomil/Hydrochlorothiazide. Dosing should be adjusted considering the patient's blood pressure response with intervals of more than 2 weeks. The recommended dosing is as follows. - 5/20/12.5 mg:

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, and administration of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to this medication or its components, have certain cardiac, kidney, or liver diseases, or are pregnant or breastfeeding should not take this medicine. It is also unsafe to administer this medication to patients with excessively low blood pressure or those who are unstable after acute myocardial infarction. Patients with decreased blood volume or impaired kidney function or liver disease should be particularly cautious when taking this medication, as hypotension or changes in kidney function may occur, and their condition should be closely monitored. As this medication lowers blood pressure, dizziness or lightheadedness may occur, necessitating caution when driving or operating hazardous machinery. During treatment, electrolyte levels in the blood and kidney function should be regularly checked to confirm there are no abnormalities. Diabetic patients or those with kidney disorders should be careful not to take this medication with certain other drugs. This medication may increase the sensitivity of the skin to sunlight, so prolonged exposure to sunlight should be avoided, and if photosensitivity symptoms appear, consultation with a doctor is recommended. In case of overdose, severe hypotension or arrhythmias may occur, requiring immediate medical attention. Safety has not been established for children or adolescents under the age of 18, and use is not recommended. Elderly patients should start at a lower dose considering decreased kidney or liver function and other diseases, and should be closely monitored.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, cough with fever along with respiratory abnormalities, yellowing of skin or eyes (jaundice), extreme lethargy across the body, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius (room temperature).

Appearance

White-orange round film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu X 3)